UPIIIa Antibodies

Santa Cruz Biotechnology features a diverse variety of UPIIIa monoclonal antibodies for investigating Uroplakin IIIa protein function. UPIIIa Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).UPIIIa is a crucial component of the urothelial cell membrane, playing a significant role in the formation of the bladder's protective barrier. Uroplakin IIIa participates in cell adhesion and signaling processes, making it essential for maintaining bladder integrity and function. Dysregulation of Uroplakin IIIa has been implicated in various urological diseases, highlighting its importance as a potential biomarker and therapeutic target. Research has shown that Uroplakin IIIa expression patterns can indicate specific pathological conditions in the urinary system. Understanding Uroplakin IIIa distribution and interactions provides valuable insights into bladder development and disease progression. Molecular studies of Uroplakin IIIa continue to reveal new aspects of urinary tract biology and pathology. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance understanding of Uroplakin IIIa's role in urological health and disease.